Nader Mousavi is widely regarded as one of the leading technology deal lawyers in the world. Nader guides industry leaders, innovators and investors on transformative transactions in artificial intelligence, digital infrastructure, semiconductors, software and other technology sectors. In recent years, Nader has been at the forefront of the rapidly developing market for AI and digital infrastructure, serving as lead counsel to OpenAI, Broadcom and other leading and emerging AI companies on their most significant transactions. Nader has advised on AI compute transactions valued at more than $1 trillion.
Nader served as lead counsel to OpenAI in its landmark partnership with Microsoft and has represented OpenAI in its strategic transactions with Oracle, Amazon/AWS, Google Cloud, CoreWeave, SoftBank Group, SB Energy and other leading technology and infrastructure providers. These transactions have helped establish the commercial and infrastructure foundations for the development, deployment and global distribution of advanced AI.
Nader also leads the representation of Broadcom in its strategic AI compute and digital infrastructure initiatives, including its landmark $63 billion financing transaction with Bank of America, Blackstone, Citi and Morgan Stanley; the establishment of its AI XPV Platform with Apollo and Blackstone, launching with a $35 billion initial transaction; and its strategic collaborations with Google and Anthropic. These representations draw on his longstanding experience advising leading semiconductor and technology companies on complex strategic alliances, technology development, licensing and commercial arrangements.
Recognized as a “Dealmaker of the Year” by The American Lawyer (2024) and “Attorney of the Year” by The Recorder (2023) as well as a Band 1 practitioner in both California Technology and Nationwide Artificial Intelligence by Chambers USA, Nader is widely regarded as one of the world's top technology deal lawyers and advisors in the field of artificial intelligence.
Nader serves on the Advisory Council of the Stanford Institute for Human-Centered AI (HAI), the world's leading institute for the advancement of AI research, education, policy and practice. He has been a Lecturer in Law at Stanford Law School since 2016, where he teaches a popular course on the Business and Law of Technology and Patent Licensing. He also serves on the Board of Visitors for Stanford Law School and is a recipient of the Governors’ Award for outstanding service to Stanford University. Earlier in his career, he served as the general counsel of a fast-growth technology company through its acquisition.
Nader’s notable representations have included:
Artificial Intelligence and Digital Infrastructure
- Broadcom in its TPU-based AI compute collaborations with Google and Anthropic
- Broadcom in the establishment of its AI XPV Platform with Apollo and Blackstone, including an initial $35 billion transaction
- Broadcom in its landmark $63 billion AI compute financing transaction with Bank of America, Blackstone, Citi and Morgan Stanley
- Broadcom in its strategic partnership with OpenAI involving the development and deployment of 10 gigawatts of custom AI accelerators
- OpenAI in its landmark partnership and subsequent strategic transactions with Microsoft, including its 2023, 2025 and 2026 agreements, including a $250 billion incremental Azure commitment
- OpenAI in its strategic compute and commercial partnerships with Amazon/AWS, including its initial $38 billion compute commitment and subsequent expanded partnership involving approximately 2 gigawatts of Trainium capacity, model commercialization and distribution of OpenAI's enterprise AI offerings
- OpenAI in strategic AI compute arrangements with Oracle (4.5 gigawatts of capacity), AMD (6 gigawatts of GPUs), CoreWeave (more than $22 billion of compute capacity), Google Cloud and Cerebras (750 megawatts of ultra-low-latency compute)
- OpenAI in its strategic partnership with SB Energy, including a $1 billion investment and collaboration to develop multi-gigawatt AI data center campuses and its landmark 20-year lease for approximately 8 gigawatts of AI compute capacity at the PORTS-Pike Technology Campus in Ohio
- OpenAI in its strategic partnership with SoftBank Group to develop and market advanced enterprise AI solutions in Japan
- Lila Sciences in strategic technology, compute and commercial matters
- Thinking Machines Lab in strategic technology, compute and commercial matters
- Twelve Labs in strategic commercial transactions with AWS as part of its Amazon Bedrock engagement
- World Labs in its strategic compute partnership with Google Cloud
Technology
- ASML in its worldwide patent cross-license with Nikon, resolving 88 pending patent cases
- AT&T in its spin-outs of DirecTV, WarnerMedia and Vrio, and DISH in transactions involving technology assets and 5G network infrastructure
- Broadcom in its licensing of rights to its Wireless IoT Connectivity Business to Synaptics
- Dolby Laboratories in commercial, licensing and other IP transactions
- Intel in the sale of its smartphone 5G modem business and associated cellular patents to Apple
- Lumus Technologies in strategic IP and commercial transactions involving augmented reality optics
- Various clients on strategic transactions opposite most major technology companies, including AMD, Apple, Google/GCP, Meta, Micron, Microsoft/Azure, Nvidia, Oracle, Samsung and TSMC
- Many leading financial institutions on strategic technology transactions and AI adoption and governance, including Ally, American Express, Goldman Sachs, JPMorgan Chase and Wells Fargo
Life Sciences
- Amgen in its $27.8 billion acquisition of Horizon Therapeutics and its $13.4 billion acquisition of Otezla
- Biohaven in its collaboration with Pfizer and its $11.6 billion sale to Pfizer
- Idenix in its $3.8 billion sale to Merck
- Kite Pharma in its $11.9 billion sale to Gilead
- Massachusetts Institute of Technology in the formation of the Broad Institute and UCLA in the establishment of the California Institute for Immunology
- MediLink in its exclusive licensing agreement with Roche
- Myovant in its collaboration with Pfizer
- Pharmasset in its $11 billion sale to Gilead
- Stemcentrx in its $9.8 billion sale to AbbVie
- Verily Life Sciences in its joint venture with Santen Pharmaceutical
Consumer
- AB InBev in its acquisition of Grupo Modelo and divestiture of U.S. rights to Corona and other brands
- Colgin Cellars in its strategic investment from LVMH
- Major League Baseball in its creation of a streaming joint venture with Disney
- McCartney Productions in an agreement with Hewlett Packard to create a private cloud for the music library of Sir Paul McCartney
- Shafer Vineyards in its sale to Starfield Properties
